Datasheet | June 19, 2026

Sefia™ Expansion System: Cell Therapy Manufacturing

Source: Cytiva
Sefia Expansion

The Sefia™ expansion system brings greater control and consistency to autologous cell therapy manufacturing by automating cell activation, transduction, and expansion within a single, functionally closed workflow. Designed to streamline operations, it enables three critical steps to run consecutively on one platform, helping reduce complexity and operator intervention. Customizable parameters and adaptable single-use kits support diverse process needs while maintaining reproducibility. Built-in automation minimizes manual touchpoints, improving productivity and resource efficiency. Real-time monitoring, alerts, and closed-system design work together to mitigate contamination risks and reduce batch failure. Seamless integration with Chronicle™ software enhances data traceability, supports compliant operations, and simplifies process duplication across sites.

See how integrated automation can help standardize and scale cell therapy manufacturing with confidence.

access the Datasheet!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma